TCDA News and Press, Tricida Inc. From 04/16/21

Today, we take our first in-depth look at Tricida, a small developmental biotech concern. The company has one late-stage asset and Stephen Cohen has acquired a significant stake in the firm through his fund Point72. A full investment analysis on this Busted IPO is presented in the...

SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to treat metabo...

Point72 Asset Management has disclosed a 5% stake in Tricida (TCDA), leading the San Francisco-based micro-cap pharmaceutical firm to gain ~5.7% in the post-market trading yesterday.The company with TRC101, a non-absorbed orally-administered polymer in its pipeline has received an i...

SOUTH SAN FRANCISCO, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to treat metabo...

Tricida, Inc. (TCDA) Q4 2020 Results Earnings Conference Call February 25, 2021, 4:30 PM ET Company Participants Jackie Cossmon - Senior Vice President, Investor Relations and Communications Gerrit Klaerner - Founder, President and CEO Geoff Parker - Chief Operating Officer and CFO Conference...

Gainers: Xtant Medical (XTNT) +189%.Intrusion (INTZ) +33%.Armstrong Flooring (AFI) +28%.Just Energy Group (JE) +28%.AMC Networks (AMCX) +26%.Applied UV (AUVI) +24%.Fisker (FSR) +21%.Ocugen (OCGN) +20%.Select Medical (SEM) +19%.Rubius Therapeutics (RUBY) +19%.Losers: Tricid...

Gainers: Xtant Medical (XTNT) +54%, Sensus Healthcare (SRTS) +34%, Rubius Therapeutics (RUBY) +23%, Select Medical (SEM) +18%, Dynavax Technologies (DVAX) +18%.Losers: Tricida (TCDA) -32%, Recro Pharma (REPH) -27%, Zynex (ZYXI) -17%,...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - February 25, 2021) - Faruqi & Faruqi, LLP, a leading national securities law fir...

Gainers: [[GRPN]] +12.8%. [[IHRT]] +10.2%. [[ACIW]] +10.1%. [[NTRA]] +8.5%. [[ETSY]] +4%.Losers: [[TCDA]] -23.1%. [[MRIN]] -12.9%. [[TPIC]] -10%. [[TUSK]] -9.6%. [[GNMK]] -9.6%. For further details see: ETSY, GRPN, TPIC and GNMK among after-hours movers

Tricida (TCDA) has plunged ~24.6% in the post-market after announcing an appeal denied letter received from the Office of New Drugs (OND) of the FDA in response to its Formal Dispute Resolution Request ("FDRR") submitted in December 2020.The FDRR related to whether the size and dura...